查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1927374

週边PMT导管市场按产品类型、导管尺寸、应用、最终用户和销售管道划分 - 全球预测（2026-2032年）

Peripheral PMT Catheter Market by Product Type, Catheter Size, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，週边 PMT 导管市场价值将达到 4.581 亿美元，到 2026 年将成长至 4.9757 亿美元，到 2032 年将达到 7.4739 亿美元，年复合成长率为 7.24%。

关键市场统计数据
基准年 2025 4.581亿美元
预计年份：2026年 4.9757亿美元
预测年份 2032 7.4739亿美元
复合年增长率 (%) 7.24%

整合临床进展、采购实务和设备性能预期，为週边PMT导管的引入建构策略背景

週边经皮机械血栓切除术（PMT）导管领域正处于不断发展的血管内技术和日益增长的微创治疗临床需求的交汇点。临床医生越来越倾向于选择导航精准、血栓切除速度快且与现有介入手术室相容的器械，而采购团队则要求产品在临床疗效、可预测的供应链和售后服务支援之间取得平衡。不断发展的器械架构和手术流程的融合，重新定义了人们对导管性能的预期，尤其是在复杂外周血管疾病的介入治疗中，因为这类疾病的血管迂曲度、血栓负荷和入路因素都存在很大差异。

技术、医疗服务模式、监管要求和供应链韧性等因素的整合如何重塑週边PMT导管的推广应用路径

週边经皮机械通气（PMT）导管的市场格局正受到多重因素的共同影响，这些因素正在重塑临床实践和商业性策略。技术进步日新月异，催生出更精密复杂的导管设计，这些设计强调导管的操控性和扭矩响应，以适应复杂的外周解剖结构。此外，辅助影像和设备整合功能的提升进一步增强了病灶的可视化效果和手术精准度，从而缩短了手术时间，并降低了经验丰富的医生操作时的併发症率。

了解2025年美国关税调整对週边PMT导管供应链重组、采购在地化和筹资策略的影响

2025年，美国关税政策的变化将对週边PMT导管的筹资策略和製造商分销逻辑产生重大影响。医疗设备及零件进口关税的提高迫使跨国製造商重新评估其产品流、定价结构和本地化计划，以保持市场竞争力。随着各机构的调整，医院和门诊中心的采购负责人正在积极探索替代货源、签订长期合约以及建立供应商伙伴关係关係，以确保设备供应稳定，同时降低短期成本波动。

多维度细分框架揭示了应用、最终用户、产品类型、销售管道和导管尺寸如何共同影响临床应用和商业策略。

市场区隔在解读週边PMT导管的需求趋势、产品开发重点和市场推广策略方面发挥核心作用。从临床应用角度来看，这些器械广泛应用于透析通路管理、栓塞治疗和周边血管疾病治疗。尤其是在周边血管疾病治疗中，根据病变特征和手术目标，会选择针对血管成形术辅助、动脉粥状硬化斑块切除术切除术辅助或标靶血栓切除术优化的器械。这些临床差异会影响器械的特性，例如管腔大小、抽吸能力以及与辅助器械的相容性。

美洲、欧洲、中东和非洲以及亚太地区在法规结构、临床实务和采购体系方面的差异，会影响医疗器材策略和市场准入。

区域趋势将对週边PMT导管的监管路径、临床实务模式和商业性推广产生重大影响。在美洲，成熟的介入性心臟病学和放射学体系、完善的医院采购框架以及对门诊血管护理日益增长的重视推动了临床应用，所有这些因素都有利于那些展现出高效操作性和临床医生熟练度的器械。该地区的监管和报销环境鼓励将器械性能与患者预后和成本控制联繫起来的证据。

PMT导管领域的竞争格局：规模、专注创新和一体化服务推动差异化并影响采购决策。

週边PMT导管市场的竞争反映了成熟医疗设备製造商和新兴专业公司并存的局面，后者专注于导管设计和手术辅助器具的创新。成熟製造商利用其广泛的临床关係、大规模生产和一体化的产品系列，提供包含导管、导管导引线和影像附件的捆绑式解决方案。其规模优势使其能够投资于多中心临床研究、广泛的培训项目以及全球分销网络，从而支持医院系统采用这些产品。

为製造商和医疗保健提供者提供切实可行的策略性倡议，以协调产品开发、证据产生和供应链模式与临床和采购优先事项。

产业领导者可以透过一系列有针对性的实用倡议，将洞察转化为竞争优势，这些倡议旨在使产品设计、商业模式和证据产生与不断变化的临床和采购需求保持一致。首先，他们应优先考虑模组化产品架构，以便快速客製化导管属性，例如直径和输送配置，同时降低库存管理的复杂性。这种方法可以减轻高容量医疗机构的物流负担，并支持临床医生在各种病例类型中快速采用此方法。

我们采用透明的混合方法调查方法，结合临床医师访谈、采购洞察和技术文献综合，得出可复製的策略结论。

本分析所依据的研究采用跨学科方法，将一手质性资料与二手技术和监管文献结合。一手资料包括对介入医师、医院和门诊中心的采购主管以及负责分销和销售策略的商业领导者的结构化访谈。这些第一手观点揭示了影响技术采纳模式的程序偏好、采购理由和营运限制。

摘要强调了整合产品创新、临床检验和供应链前瞻性对于实现週边PMT导管的持续应用的重要性。

週边经皮机械取栓（PMT）导管市场的特点是技术快速创新、医疗服务模式不断变化以及对供应链韧性的日益重视。成功驾驭此环境需要临床价值提案与切实可行的商业性执行方案相契合。临床医生需要能够提高手术精准度和改善患者预后的器械，而采购团队则需要可预测的供应和可证明的整体成本效益。製造商必须透过实证医学证据、培训和可靠的物流保障来满足这些需求。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 週边PMT导管市场（依产品类型划分）

  • 越过电线
  • 快速交换类型
  • 专业化配送系统
    • 可转向
    • 扭力控制

9. 依导管尺寸分類的周边PMT导管市场

  • 大直径 > 3.5F
  • 中等直径 2.5-3.5F
  • 小直径<2.5F

第十章 依应用分類的外周PMT导管市场

  • 透析通路管理
  • 栓塞术
  • 週边血管疾病治疗
    • 血管成形术
    • 动脉粥状硬化斑块切除术
    • 血栓切除术

第十一章 週边PMT导管市场（依最终用户划分）

  • 门诊手术中心
  • 医院
  • 专科诊所

第十二章 週边PMT导管市场（依销售管道划分）

  • 直销
  • 批发的

13. 週边PMT导管市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 週边PMT导管市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国週边PMT导管市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国週边PMT导管市场

第十七章：中国週边PMT导管市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Inari Medical, Inc.
  • Koninklijke Philips NV
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-4F7A6D4FF382

The Peripheral PMT Catheter Market was valued at USD 458.10 million in 2025 and is projected to grow to USD 497.57 million in 2026, with a CAGR of 7.24%, reaching USD 747.39 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 458.10 million
Estimated Year [2026] USD 497.57 million
Forecast Year [2032] USD 747.39 million
CAGR (%) 7.24%

Framing the strategic context for peripheral PMT catheter adoption by synthesizing clinical advances, procurement realities, and device performance expectations

The peripheral percutaneous mechanical thrombectomy (PMT) catheter segment sits at the intersection of advancing endovascular techniques and intensifying clinical demand for minimally invasive therapies. Clinicians increasingly prefer devices that offer precise navigation, rapid thrombus removal, and compatibility with existing interventional suites, while procurement teams seek products that balance clinical effectiveness with predictable supply chains and service support. The confluence of evolving device architectures and procedural workflows has redefined expectations for catheter performance, particularly in complex peripheral vascular disease interventions where vessel tortuosity, thrombus burden, and access considerations vary widely.

Against this backdrop, stakeholders from clinicians to commercial leaders require an integrated perspective that synthesizes clinical innovation, regulatory precedence, and operational realities. New iterations of PMT catheters emphasize deliverability, control, and patient safety, and these attributes now play a dominant role in hospital and ambulatory center adoption decisions. As a result, competitive positioning is shaped by technical differentiation and post-market evidence-generation, while reimbursement and procurement cycles influence the pace at which novel devices transition from early adopters to broader clinical practice.

This introductory review provides a framework for understanding device intent, clinical utility, and market traction drivers, enabling readers to contextualize technical developments and strategic initiatives within a rapidly evolving clinical environment.

How converging forces in technology, care delivery models, regulatory expectations, and supply chain resilience are reshaping peripheral PMT catheter adoption pathways

The landscape for peripheral PMT catheters is being transformed by multiple, intersecting shifts that are reshaping clinical practice and commercial priorities. Technological evolution has accelerated with more sophisticated catheter designs that emphasize steerability and torque response to negotiate complex peripheral anatomies. These hardware improvements are reinforced by adjunctive imaging and device integration capabilities that improve lesion visualization and procedural precision, which in turn lower procedural times and reduce complication rates in experienced hands.

Simultaneously, care delivery models are migrating toward ambulatory and outpatient settings where cost pressures and throughput considerations demand devices that minimize procedural complexity and support rapid patient turnover. Hospitals are responding by prioritizing capital allocation toward devices that demonstrate operational efficiencies and predictable learning curves. At the same time, regulatory scrutiny and post-market surveillance mechanisms have intensified, prompting manufacturers to invest in robust clinical evidence and rigorous quality systems to support broader adoption and payer engagement.

In addition, supply chain resilience and localized manufacturing capabilities have gained prominence after recent global disruptions, motivating manufacturers and distributors to reassess distribution networks and inventory strategies. These cumulative shifts emphasize interoperability, clinical outcome validation, and the ability to deliver consistent performance across diverse care environments, all of which directly influence procurement decisions and long-term product viability.

Understanding how US tariff adjustments in 2025 are prompting supply chain reconfiguration, sourcing localization, and procurement strategies for peripheral PMT catheters

In 2025, tariff changes in the United States exert a tangible influence on procurement strategies and manufacturer distribution logic for peripheral PMT catheters. Increased import levies on medical devices and component parts prompt multinational manufacturers to reassess product flows, pricing structures, and localization plans to maintain market competitiveness. As organizations adapt, procurement leaders in hospitals and ambulatory centers respond by seeking alternative sourcing arrangements, longer-term contracts, and supplier partnerships that can mitigate short-term cost volatility while securing device availability.

The tariff environment also catalyzes discussions about local manufacturing and final assembly, encouraging some manufacturers to accelerate investments in regional production to reduce duty exposure and enhance supply chain control. Such moves carry capital and operational implications but can yield benefits in lead time reduction and regulatory alignment for devices intended for the U.S. clinical market. For smaller suppliers and distributors, tariff-driven cost pressures can compress margins and necessitate adjustments in sales strategies, including value-added services or differentiated warranty and training propositions to retain customers.

Clinicians and hospital administrators navigate these changes by emphasizing total cost of ownership and clinical value rather than unit price alone. Payors and purchasing groups increasingly expect transparent lifecycle cost data and may prefer suppliers that demonstrate both supply continuity and commitment to clinician education. The net effect of tariff shifts is a renewed focus on supply chain diversification, manufacturing footprint strategy, and contractual protections to safeguard clinical access and fiscal predictability.

A multidimensional segmentation framework revealing how application, end-user, product type, sales channels, and catheter size collectively shape clinical adoption and commercial strategy

Segmentation is central to interpreting demand dynamics, product development priorities, and go-to-market tactics for peripheral PMT catheters. When viewed through the lens of clinical application, devices are deployed across dialysis access management, embolization procedures, and peripheral vascular disease treatment; within the latter, operators select tools optimized for angioplasty adjuncts, atherectomy support, or targeted thrombectomy interventions depending on lesion characteristics and procedural intent. These clinical distinctions influence device features such as lumen size, aspiration capability, and compatibility with adjunctive devices.

From the perspective of end users, adoption pathways vary across ambulatory surgical centers, hospitals, and specialty clinics. Ambulatory centers often prioritize rapid turnover and user-friendly systems that lower staffing burden, hospitals require devices that integrate with complex imaging and support multidisciplinary teams, and specialty clinics emphasize targeted performance for high-volume disease types. These care setting differences shape training requirements, inventory policies, and purchasing cadences.

Product-type segmentation differentiates over-the-wire systems from rapid exchange platforms and specialty delivery systems; the latter category includes steerable designs and torque-control architectures that confer enhanced navigational precision in tortuous anatomy. Sales channel distinctions between direct sales and distributor sales influence commercial engagement models, with direct sales often enabling tailored corporate sales relationships and distributor networks providing breadth and logistical depth. Finally, catheter size is a practical differentiator, with large diameters greater than 3.5F, medium diameters ranging from 2.5 to 3.5F, and small diameters under 2.5F guiding clinician choice based on vessel access, thrombus burden, and procedural compatibility. Together, these segmentation axes provide a multidimensional framework that informs R&D priorities, clinical training investments, and market entry strategies.

How divergent regulatory frameworks, clinical practices, and procurement ecosystems across the Americas, Europe Middle East & Africa, and Asia-Pacific influence device strategy and market entry

Regional dynamics exert a material influence on regulatory pathways, clinical practice patterns, and commercial execution for peripheral PMT catheters. In the Americas, clinical adoption is driven by established interventional cardiology and radiology ecosystems, robust hospital procurement frameworks, and a rising emphasis on outpatient vascular care, all of which favor devices that demonstrate operational efficiency and clinician familiarity. The region's regulatory and reimbursement environments encourage evidence generation that links device performance to patient outcomes and cost containment.

Europe, Middle East & Africa present heterogeneous landscapes where regulatory frameworks vary significantly across jurisdictions and where healthcare delivery models range from centralized national health systems to private, fee-for-service clinics. Manufacturers operating in this combined region must navigate diverse approval processes and tailor clinical engagement strategies to local hospital procurement norms. Reimbursement models and varying resource availability influence device selection, making flexible pricing and training programs important to achieving broader penetration.

In Asia-Pacific, demand is shaped by rapid expansion of interventional facilities, increasing clinician specialization, and government-driven investments in healthcare infrastructure. Markets within the region differ in payer structure and regulatory maturity, prompting manufacturers to adapt clinical evidence packages and distribution approaches accordingly. Across these three regional clusters, success depends on aligning product portfolios with local procedural preferences, regulatory timelines, and supply chain realities to support sustainable adoption.

Competitive landscape dynamics where scale, focused innovation, and integrated service offerings determine differentiation and influence procurement decisions within the PMT catheter sector

Competitive dynamics in peripheral PMT catheters reflect the presence of established medical device manufacturers and emerging specialized firms that bring focused innovation in catheter design and procedural adjuncts. Incumbent device makers leverage broad clinical relationships, large-scale manufacturing, and integrated product portfolios to offer bundled solutions that encompass catheters, guidewires, and imaging accessories. Their scale enables investments in multicenter clinical studies, extensive training programs, and global distribution infrastructures that support hospital system adoption.

Smaller and specialized companies differentiate through rapid iteration, niche-focused design enhancements, and closer collaboration with key opinion leaders to refine device performance for specific clinical indications. These firms often compete on unique technical attributes such as enhanced steerability, improved aspiration mechanics, or proprietary clot fragmentation technologies. Partnerships and licensing arrangements between larger firms and innovators can accelerate commercialization while preserving the R&D agility of smaller players.

Distributors and regional partners play a pivotal role by extending reach into ambulatory centers and specialty clinics, offering logistical support and local training. The competitive battlefield increasingly includes services such as hands-on procedural training, digital education platforms, and data-driven post-market surveillance offerings. Ultimately, firms that combine compelling clinical evidence, responsive supply chains, and integrated service offerings are best positioned to influence purchasing committees and procedural leaders.

Actionable strategic initiatives for manufacturers and healthcare providers to align product development, evidence generation, and supply chain models with clinical and procurement priorities

Industry leaders can translate insights into competitive advantage through a set of targeted, actionable initiatives that align product design, commercial models, and evidence generation with evolving clinical and procurement expectations. First, prioritize modular product architectures that allow rapid customization of catheter attributes such as diameter and delivery configuration while limiting the complexity of inventory management. This approach reduces the logistical burden on high-volume centers and supports rapid clinician adoption across diverse case types.

Second, invest in robust clinical evidence programs that pair pragmatic outcomes data with health economics analyses; demonstrating procedural efficiency and patient recovery benefits will resonate with hospital purchasing committees and payers. Complementary to evidence generation, develop structured training and proctoring programs that shorten learning curves and reinforce consistent outcomes across user groups and care settings. These programs should be delivered through a combination of hands-on workshops, simulation, and digital learning platforms to scale effectively.

Third, reassess supply chain strategies by exploring regional manufacturing or final assembly options, strengthening distributor relationships, and negotiating flexible contract terms that address tariff-related risks. Fourth, refine commercial engagement by offering differentiated sales models that combine direct enterprise relationships for large systems with distributor-led coverage for ambulatory and specialty clinic segments. Finally, maintain a pipeline of iterative product improvements that respond to clinician feedback on navigation, aspiration efficacy, and compatibility with adjunctive devices, sustaining both clinical relevance and commercial momentum.

A transparent mixed-methods research approach combining clinician interviews, procurement insights, and technical literature synthesis to support reproducible strategic conclusions

The research underpinning this analysis integrates a cross-functional approach that synthesizes primary qualitative inputs with secondary technical and regulatory literature. Primary inputs include structured interviews with interventional physicians, procurement executives across hospitals and ambulatory centers, and commercial leaders responsible for distribution and sales strategy. These firsthand perspectives illuminate procedural preferences, purchasing rationales, and operational constraints that shape adoption patterns.

Secondary inputs incorporate device design specifications, regulatory filing summaries, peer-reviewed clinical literature on catheter-based thrombectomy techniques, and public information on commercial distribution models. Data interrogation emphasized device architecture features such as delivery mechanisms, size gradations, and integration with imaging modalities. Cross-validation between primary stakeholder insights and secondary documentation ensured that conclusions reflect both frontline clinical practice and broader industry trends.

Analytical methods included thematic synthesis of interview findings, comparative device feature mapping, and scenario-based assessment of supply chain and regulatory variables. The methodology prioritized transparency in assumptions and traceability of qualitative evidence to support reproducible interpretations and to aid readers in applying findings to their strategic contexts.

Concluding synthesis emphasizing the need to unite product innovation, clinical validation, and supply chain foresight to achieve durable adoption of peripheral PMT catheters

The peripheral PMT catheter environment is characterized by rapid technical refinement, shifting care delivery patterns, and heightened emphasis on supply chain resilience. Successful navigation of this environment requires alignment between clinical value propositions and pragmatic commercial execution. Clinicians seek devices that improve procedural precision and patient outcomes, while procurement teams demand predictable supply and demonstrable total cost benefits; manufacturers must bridge these priorities through evidence, training, and logistical reliability.

As the sector evolves, organizations that integrate iterative product innovation with robust clinical engagement and flexible supply strategies will be best positioned to influence adoption. Regional nuances in regulation and procurement necessitate tailored market approaches, and tariff-induced pressures accelerate considerations around localized manufacturing and contract design. Competitive advantage increasingly depends on the ability to deliver integrated solutions that combine technical differentiation with service-oriented commercial models that answer the needs of diverse care settings.

In sum, a holistic strategy that unites product engineering, clinical validation, and supply-chain foresight will enable stakeholders to translate technological progress into sustainable clinical and commercial outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral PMT Catheter Market, by Product Type

  • 8.1. Over The Wire
  • 8.2. Rapid Exchange
  • 8.3. Specialty Delivery Systems
    • 8.3.1. Steerable
    • 8.3.2. Torque Control

9. Peripheral PMT Catheter Market, by Catheter Size

  • 9.1. Large Diameter >3.5F
  • 9.2. Medium Diameter 2.5-3.5F
  • 9.3. Small Diameter <2.5F

10. Peripheral PMT Catheter Market, by Application

  • 10.1. Dialysis Access Management
  • 10.2. Embolization
  • 10.3. Peripheral Vascular Disease Treatment
    • 10.3.1. Angioplasty
    • 10.3.2. Atherectomy
    • 10.3.3. Thrombectomy

11. Peripheral PMT Catheter Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Peripheral PMT Catheter Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. Distributor Sales

13. Peripheral PMT Catheter Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Peripheral PMT Catheter Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Peripheral PMT Catheter Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Peripheral PMT Catheter Market

17. China Peripheral PMT Catheter Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AngioDynamics, Inc.
  • 18.6. Argon Medical Devices, Inc.
  • 18.7. Becton, Dickinson and Company
  • 18.8. Boston Scientific Corporation
  • 18.9. Inari Medical, Inc.
  • 18.10. Koninklijke Philips N.V.
  • 18.11. Medtronic plc
  • 18.12. Merit Medical Systems, Inc.
  • 18.13. Penumbra, Inc.
  • 18.14. Teleflex Incorporated
  • 18.15. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL PMT CATHETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL PMT CATHETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY OVER THE WIRE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY OVER THE WIRE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY OVER THE WIRE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY RAPID EXCHANGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY RAPID EXCHANGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY RAPID EXCHANGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY STEERABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY STEERABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY STEERABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY TORQUE CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY TORQUE CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY TORQUE CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY LARGE DIAMETER >3.5F, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY LARGE DIAMETER >3.5F, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY LARGE DIAMETER >3.5F, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY MEDIUM DIAMETER 2.5-3.5F, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY MEDIUM DIAMETER 2.5-3.5F, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY MEDIUM DIAMETER 2.5-3.5F, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SMALL DIAMETER <2.5F, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SMALL DIAMETER <2.5F, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SMALL DIAMETER <2.5F, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DIALYSIS ACCESS MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DIALYSIS ACCESS MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DIALYSIS ACCESS MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY THROMBECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY THROMBECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY THROMBECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 143. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 146. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 167. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 170. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 175. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 178. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)